Supplements to Sickle Cell Disease Newborn Screening Follow-up Program Recipients (HRSA-21-036), 56639-56640 [2023-17805]
Download as PDF
<![CDATA[
56639
Federal Register / Vol. 88, No. 159 / Friday, August 18, 2023 / Notices
63. Emory Garrett, Duarte, California, Court
of Federal Claims No: 23–0924V
64. Jay M. Burrows, Clayton, New York,
Court of Federal Claims No: 23–0925V
65. Teresa Jupiter, Florence, South Carolina,
Court of Federal Claims No: 23–0927V
66. Jacqueline London, Morris Plains, New
Jersey, Court of Federal Claims No: 23–
0929V
67. Mary Mahoney, Ellston, Iowa, Court of
Federal Claims No: 23–0932V
68. Alexandra Cumming, Phoenix, Arizona,
Court of Federal Claims No: 23–0937V
69. Rebecca J. Barger, Honolulu, Hawaii,
Court of Federal Claims No: 23–0939V
70. Vicki Mullin, Paso Robles, California,
Court of Federal Claims No: 23–0940V
71. Lisa Bakke, Seattle, Washington, Court of
Federal Claims No: 23–0941V
72. Nancy Ann Buccigrossi, Wellesley,
Massachusetts, Court of Federal Claims
No: 23–0943V
73. Elizabeth Pomales-Rodriguez, Wellington,
Florida, Court of Federal Claims No: 23–
0945V
74. Daniel Alam, Boston, Massachusetts,
Court of Federal Claims No: 23–0947V
75. Sharon Kawashiri, Torrance, California,
Court of Federal Claims No: 23–0949V
76. Hannah Ellis, Fort Wayne, Indiana, Court
of Federal Claims No: 23–0962V
77. Sylvester Barnes, III, Orange, Ohio, Court
of Federal Claims No: 23–0963V
78. Nicole Scammell on behalf of V. S.,
Commack, New York, Court of Federal
Claims No: 23–0974V
79. Renae Walker, Atlanta, Georgia, Court of
Federal Claims No: 23–0978V
80. Sheryl Leturgey on behalf of B. L.,
Oswego, Illinois, Court of Federal Claims
No: 23–0979V
81. Christine Avery, Seattle, Washington,
Court of Federal Claims No: 23–0984V
82. Michael Goncalves, Sacramento,
California, Court of Federal Claims No:
23–0985V
83. Garrett Dolling, Reno, Nevada, Court of
Federal Claims No: 23–0986V
84. Ainsley McLaughlin, Phoenix, Arizona,
Court of Federal Claims No: 23–0987V
85. Robert Wilson, Houston, Texas, Court of
Federal Claims No: 23–0988V
86. Avery Carter, Harlan, Iowa, Court of
Federal Claims No: 23–0989V
87. Linda McCurdy, Lancaster, Pennsylvania,
Court of Federal Claims No: 23–0990V
88. Brenda Coles-Jacobs, Feasterville,
Pennsylvania, Court of Federal Claims
No: 23–0991V
89. Alexis Rodriguez, Phoenix, Arizona,
Court of Federal Claims No: 23–0992V
90. Darlene Roberts, Boston, Massachusetts,
Court of Federal Claims No: 23–0993V
91. Kathy Sanders, Newnan, Georgia, Court
of Federal Claims No: 23–0996V
92. Joanne Doherty, Boston, Massachusetts,
Court of Federal Claims No: 23–0998V
93. Leysa Stotelmyer, Harrisburg,
Pennsylvania, Court of Federal Claims
No: 23–1001V
94. Gisella Vargas, Neptune, New Jersey,
Court of Federal Claims No: 23–1010V
95. Terrill O’Brien, Glassboro, New Jersey,
Court of Federal Claims No: 23–1011V
96. Louis Massa, Akron, Ohio, Court of
Federal Claims No: 23–1012V
97. Daisy Jutting, Hayti, South Dakota, Court
of Federal Claims No: 23–1014V
98. Amanda Rivera on behalf of A. R.,
Phoenix, Arizona, Court of Federal
Claims No: 23–1017V
99. Kelly Joyner, Columbia, South Carolina,
Court of Federal Claims No: 23–1020V
[FR Doc. 2023–17795 Filed 8–17–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Supplemental Award;
Women’s Preventive Services Initiative
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of supplemental award.
AGENCY:
HRSA is providing
supplemental funds not to exceed
$449,000 to the Women’s Preventive
Services Initiative (WPSI) in fiscal year
2023.
FOR FURTHER INFORMATION CONTACT:
Kimberly Sherman, Chief, Maternal and
Women’s Health Branch, Division of
Healthy Start and Perinatal Services,
Maternal and Child Health Bureau,
HRSA, at ksherman@hrsa.gov and 301–
443–1702.
SUPPLEMENTARY INFORMATION: Intended
Recipient of the Award: One award to
American College of Obstetricians and
Gynecologists (ACOG), the current
recipient under WPSI, as listed in Table
1.
Amount of Non-Competitive Award:
One award up to $449,000.
Project Period: March 1, 2021, to
February 28, 2026.
CFDA Number: 93.110.
Award Instrument: Supplement.
Authority: 42 U.S.C. 701(a)(2) (title V,
section 501(a)(2) of the Social Security
Act).
SUMMARY:
TABLE 1—WPSI AWARD RECIPIENT
lotter on DSK11XQN23PROD with NOTICES1
[2021–2026]
Grant No.
Award recipient name
City, state
UH0MC29440 ..........................
American College of Obstetricians and Gynecologists ...........
Washington, DC ......................
Justification: Supplemental funding
under this award will enhance HRSA’s
efforts to disseminate the Women’s
Preventive Service Guidelines and
increase knowledge of the guidelines in
standard clinical practice. The planned
supplemental award to ACOG is within
the scope of the most recent funding
opportunity’s (HRSA–21–045) program
purpose, which aims to improve
women’s health across the lifespan. The
supplemental funding, not to exceed
$449,000, will support the
Award amount
$449,000
implementation and expansion of
program education and outreach.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Carole Johnson,
Administrator.
Health Resources and Services
Administration
[FR Doc. 2023–17808 Filed 8–17–23; 8:45 am]
BILLING CODE 4165–15–P
Supplements to Sickle Cell Disease
Newborn Screening Follow-up
Program Recipients (HRSA–21–036)
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of supplemental awards.
AGENCY:
HRSA will provide
supplemental award funds to all 25
Sickle Cell Disease (SCD) Newborn
Screening (NBS) Follow-up Program
SUMMARY:
VerDate Sep<11>2014
18:26 Aug 17, 2023
Jkt 259001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\18AUN1.SGM
18AUN1
56640
Federal Register / Vol. 88, No. 159 / Friday, August 18, 2023 / Notices
(FP) grantees for $56,000 each for fiscal
year 2023. The funds will support inscope grant activities related to health
care services, increasing access to
medical and social support services, and
conducting outreach to help connect
individuals living with SCD to followup care.
FOR FURTHER INFORMATION CONTACT:
Hakim Fobia, Public Health Analyst and
Project Officer, Genetic Services Branch,
Division of Services for Children with
Special Health Needs, Maternal and
Child Health Bureau (MCHB), HRSA, at
scdprograms@hrsa.gov or (301) 945–
9842.
Intended
Recipients of the Award: 25 SCD NBS
FP recipients as listed in Table 1.
SUPPLEMENTARY INFORMATION:
Amount of Non-Competitive Awards:
25 awards at $56,000 (total: $1,400,000).
Project Period: September 1, 2023, to
August 31, 2024.
CFDA Number: 93.110.
Award Instrument: Supplement.
Authority: 42 U.S.C. 701(a)(2)
(§ 501(a)(2) of the Social Security Act).
TABLE 1—RECIPIENTS AND AWARD AMOUNTS
Grant No.
Award recipient name
City, state
D1J42466 ................................
D1J42474 ................................
D1J42475 ................................
D1J42467 ................................
D1JMC42468 ...........................
D1JMC42463 ...........................
D1JMC42472 ...........................
D1JMC42473 ...........................
D1JMC42471 ...........................
D1JMC42476 ...........................
D1JMC42470 ...........................
D1JMC42477 ...........................
D1JMC42469 ...........................
Sickle Cell Disease Association of Illinois ...............................
Hemostasis and Thrombosis Center of Nevada ......................
Ohio Sickle Cell & Health Association, Inc ..............................
Martin Center, Inc. ...................................................................
Baton Rouge Sickle Cell Anemia Foundation, Inc ..................
Cayenne Wellness Center and Children’s Foundation, Inc. ....
Children’s Sickle Cell Foundation Inc ......................................
Clark, James R Memorial Sickle Cell Foundation ...................
Piedmont Health Services and Sickle Cell Agency .................
Sickle Cell Anemia Foundation of Oregon, Inc. ......................
Sickle Cell Association .............................................................
The Sickle Cell Association Of New Jersey, Inc. ....................
Sickle Cell Disease Association of America Michigan Chapter
Inc.
Sickle Cell Disease Association of America Philadelphia—
Delaware Valley Chapter.
Sickle Cell Foundation of Arizona, Inc. ....................................
Sickle Cell Foundation of Georgia, Inc. ...................................
Sickle Cell Texas Marc Thomas Foundation ...........................
Sickle Cell/Thalassemia Patients Networks, Inc. .....................
Supporters of Families with Sickle Cell Disease, Incorporated
University of Miami ...................................................................
Sickle Cell Disease Foundation ...............................................
Sickle Cell Disease Association of America Mobile Chapter ..
Crescent Foundation, Inc. ........................................................
Metropolitan Seattle Sickle Cell Task Force ............................
Sickle Cell Foundation of Tennessee ......................................
Chicago, IL ..............................
Las Vegas, NV ........................
Columbus, OH ........................
Indianapolis, IN .......................
Baton Rouge, LA ....................
Burbank, CA ...........................
Pittsburgh, PA .........................
Columbia, SC ..........................
Greensboro, NC ......................
Portland, OR ...........................
Florissant, MO ........................
Newark, NJ .............................
Detroit, MI ...............................
$56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
Philadelphia, PA .....................
56,000
Vail, AZ ...................................
Atlanta, GA .............................
Austin, TX ...............................
Brooklyn, NY ...........................
Tulsa, OK ................................
Miami, FL ................................
Ontario, CA .............................
Mobile, AL ...............................
Philadelphia, PA .....................
Seattle, WA .............................
Memphis, TN ..........................
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
56,000
D1JMC42478 ...........................
lotter on DSK11XQN23PROD with NOTICES1
D1JMC42462
D1JMC42465
D1JMC42479
D1JMC42480
D1JMC42481
D1JMC42464
D1JMC46837
D1JMC46836
D1JMC46834
D1JMC46835
D1JMC46838
...........................
...........................
...........................
...........................
...........................
...........................
...........................
...........................
...........................
...........................
...........................
Justification: The Consolidated
Appropriations Act, 2023 (Pub. L. 117–
328) provided MCHB with additional
appropriations for the Sickle Cell
Disease Newborn Screening Follow-up
Program. The Program currently funds
25 community-based organizations to
facilitate access to quality SCD care.
MCHB will provide a supplement of
$56,000 to each of the 25 existing
grantees, as outlined in Table 1. Funds
will support in-scope grant activities
related to health care services,
increasing access to medical and social
support services, and conducting
outreach to help connect individuals
living with SCD to follow up care.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Carole Johnson,
Administrator.
SUMMARY:
[FR Doc. 2023–17805 Filed 8–17–23; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
18:26 Aug 17, 2023
Jkt 259001
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Evidence
Based Telehealth Network Program
Measures, OMB No. 0906–0043—
Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Award amount
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than October 17, 2023.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Joella Roland, the HRSA
Information Collection Clearance
Officer, at (301) 443–3983.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
Evidence Based Telehealth Network
Program Measures, OMB No. 0906–
0043—Revision.
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 88, Number 159 (Friday, August 18, 2023)]
[Notices]
[Pages 56639-56640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17805]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Supplements to Sickle Cell Disease Newborn Screening Follow-up
Program Recipients (HRSA-21-036)
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice of supplemental awards.
-----------------------------------------------------------------------
SUMMARY: HRSA will provide supplemental award funds to all 25 Sickle
Cell Disease (SCD) Newborn Screening (NBS) Follow-up Program
[[Page 56640]]
(FP) grantees for $56,000 each for fiscal year 2023. The funds will
support in-scope grant activities related to health care services,
increasing access to medical and social support services, and
conducting outreach to help connect individuals living with SCD to
follow-up care.
FOR FURTHER INFORMATION CONTACT: Hakim Fobia, Public Health Analyst and
Project Officer, Genetic Services Branch, Division of Services for
Children with Special Health Needs, Maternal and Child Health Bureau
(MCHB), HRSA, at [email protected] or (301) 945-9842.
SUPPLEMENTARY INFORMATION: Intended Recipients of the Award: 25 SCD NBS
FP recipients as listed in Table 1.
Amount of Non-Competitive Awards: 25 awards at $56,000 (total:
$1,400,000).
Project Period: September 1, 2023, to August 31, 2024.
CFDA Number: 93.110.
Award Instrument: Supplement.
Authority: 42 U.S.C. 701(a)(2) (Sec. 501(a)(2) of the Social
Security Act).
Table 1--Recipients and Award Amounts
----------------------------------------------------------------------------------------------------------------
Grant No. Award recipient name City, state Award amount
----------------------------------------------------------------------------------------------------------------
D1J42466.............................. Sickle Cell Disease Chicago, IL............. $56,000
Association of Illinois.
D1J42474.............................. Hemostasis and Thrombosis Las Vegas, NV........... 56,000
Center of Nevada.
D1J42475.............................. Ohio Sickle Cell & Health Columbus, OH............ 56,000
Association, Inc.
D1J42467.............................. Martin Center, Inc............ Indianapolis, IN........ 56,000
D1JMC42468............................ Baton Rouge Sickle Cell Anemia Baton Rouge, LA......... 56,000
Foundation, Inc.
D1JMC42463............................ Cayenne Wellness Center and Burbank, CA............. 56,000
Children's Foundation, Inc..
D1JMC42472............................ Children's Sickle Cell Pittsburgh, PA.......... 56,000
Foundation Inc.
D1JMC42473............................ Clark, James R Memorial Sickle Columbia, SC............ 56,000
Cell Foundation.
D1JMC42471............................ Piedmont Health Services and Greensboro, NC.......... 56,000
Sickle Cell Agency.
D1JMC42476............................ Sickle Cell Anemia Foundation Portland, OR............ 56,000
of Oregon, Inc..
D1JMC42470............................ Sickle Cell Association....... Florissant, MO.......... 56,000
D1JMC42477............................ The Sickle Cell Association Of Newark, NJ.............. 56,000
New Jersey, Inc..
D1JMC42469............................ Sickle Cell Disease Detroit, MI............. 56,000
Association of America
Michigan Chapter Inc.
D1JMC42478............................ Sickle Cell Disease Philadelphia, PA........ 56,000
Association of America
Philadelphia--Delaware Valley
Chapter.
D1JMC42462............................ Sickle Cell Foundation of Vail, AZ................ 56,000
Arizona, Inc..
D1JMC42465............................ Sickle Cell Foundation of Atlanta, GA............. 56,000
Georgia, Inc..
D1JMC42479............................ Sickle Cell Texas Marc Thomas Austin, TX.............. 56,000
Foundation.
D1JMC42480............................ Sickle Cell/Thalassemia Brooklyn, NY............ 56,000
Patients Networks, Inc..
D1JMC42481............................ Supporters of Families with Tulsa, OK............... 56,000
Sickle Cell Disease,
Incorporated.
D1JMC42464............................ University of Miami........... Miami, FL............... 56,000
D1JMC46837............................ Sickle Cell Disease Foundation Ontario, CA............. 56,000
D1JMC46836............................ Sickle Cell Disease Mobile, AL.............. 56,000
Association of America Mobile
Chapter.
D1JMC46834............................ Crescent Foundation, Inc...... Philadelphia, PA........ 56,000
D1JMC46835............................ Metropolitan Seattle Sickle Seattle, WA............. 56,000
Cell Task Force.
D1JMC46838............................ Sickle Cell Foundation of Memphis, TN............. 56,000
Tennessee.
----------------------------------------------------------------------------------------------------------------
Justification: The Consolidated Appropriations Act, 2023 (Pub. L.
117-328) provided MCHB with additional appropriations for the Sickle
Cell Disease Newborn Screening Follow-up Program. The Program currently
funds 25 community-based organizations to facilitate access to quality
SCD care. MCHB will provide a supplement of $56,000 to each of the 25
existing grantees, as outlined in Table 1. Funds will support in-scope
grant activities related to health care services, increasing access to
medical and social support services, and conducting outreach to help
connect individuals living with SCD to follow up care.
Carole Johnson,
Administrator.
[FR Doc. 2023-17805 Filed 8-17-23; 8:45 am]
BILLING CODE 4165-15-P
